Events and Conferences

Contact Veristat Now


Request A Proposal

Contact Us

Webinar | Achieving Balance in Clinical Trial Database Design: Considerations for Enhancing Clinical Trial Efficiency

November 14, 2019

Webinar Summary:

Designing a clinical trial database is a balancing act.  Any clinical program has multiple stakeholders who have both short-term and long-term goals to achieve.   A good database designer must understand the needs and goals of the sponsor and its various functional project team members.   The designer must consider the ease of use for the clinical trial sites who will be entering the trial data, with the needs of the downstream stakeholders in biostatistics, programming, and medical writing.  Additionally, we not only need to consider today’s priorities, we also must understand the overall strategy of the clinical program, especially as it moves forward past the current stage.  

Read More

Outsourcing in Clinical Trials East 2019 | Booth #7

April 23, 2019

Meet Veristat at booth #7 at the upcoming OCT East 2019 event taking place in King of Prussia, PA on May 21-22, 2019

We provide impactful strategies and solutions to meet your outsourcing needs in order to plan and run your next clinical trial, program or regulatory submission project.  

Read More

Meet With Veristat at the ASH Annual Meeting 2018

November 26, 2018

Veristat will attend the upcoming ASH Annual Meeting 2018 taking place in San Diego, California from Dec 1-4, 2018, the premier event in malignant and non-malignant hematology.

Read More

Outsourcing in Clinical Trials Southern California 2018

August 29, 2018

Meet Veristat at booth # 24 at OCT SoCal 2018!    As a full service CRO providing impactful strategies and solutions, Veristat can meet all of your outsourcing needs  to support your next clinical trial, program or regulatory submission project. 

Read More

Meet Veristat at SCDM 2018!

August 28, 2018

 

Join Veristat Data Managers at the No. 1 Clinical Data Management Event, SCDM 2018! The event takes place this year on September 23-26 in Seattle, WA.

Read More

Outsourcing in Clinical Trials East Coast | Explore Challenges & Solutions In Clinical Trial Outsourcing

April 30, 2018

Are you looking to discover more effective strategies for outsourcing your clinical trial operations and marketing application development to ensure that  your trial runs smoothly and within budget?  

Then meet up with Veristat at booth #74, at the Outsourcing in Clinical Trials East Coast 2018 event.  

Read More

DIA Europe 2018 |  Catch Up With Veristat in Europe

March 8, 2018

Join Veristat and other drug development specialists at the DIA Europe Annual Meeting 2018 taking place in Basel, Switzerland.   This event allows for the open collaboration of ideas and solutions needed to drive the progression of drug development.    It brings together regulatory agencies, sponsors, patients and advocates to meet at the “crossroads of healthcare”, the theme at this year’s meeting.

Read More

SQA Annual Meeting | View Our Poster Presentation on Implementing an eTMF

March 6, 2018

Implementing an electronic Trial Master File (eTMF) isn’t as simple as it sounds, though having successfully implemented one last year makes Veristat’s Corporate Compliance leader the best person to learn from.   And, she will be attending the 34th Annual Society of Quality Assurance Annual Meeting to share her insights and lessons learned from this implementation.

Read More

Webinar: Sponsors & CROs Explore CRO Consolidation

March 6, 2018

Veristat recently participated in the webinar titled "CRO Consolidation: A Sinister Threat or Windfall for Pharma?"   View a recording of the webcast now.

Read More

ASH Annual Meeting  | Supporting Blood Cancer Clinical Trials

November 28, 2017

Veristat is excited to head to Atlanta, GA for the 59th ASH Annual Meeting & Exposition taking place from December 9-12, 2017.   The 2017 ASH Annual Meeting is the place to  network with a global community of more than 25,000 hematology professionals who specialize in performing clinical research and treating patients with both malignant and non-malignant hematology diseases. 

Read More